APA (7th ed.) Citation

Y, S., HE, B., SE, C., Y, K., YJ, H., SB, K., . . . KW, L. (2026). Epigenetic inhibition of class I histone deacetylases by MS-275 attenuates diabetic skeletal muscle atrophy via Akt/ARK5-FoxO and myostatin-Smad signaling. Frontiers in endocrinology, 17, 1788603. https://doi.org/10.3389/fendo.2026.1788603

Chicago Style (17th ed.) Citation

Y, Son, et al. "Epigenetic Inhibition of Class I Histone Deacetylases by MS-275 Attenuates Diabetic Skeletal Muscle Atrophy via Akt/ARK5-FoxO and Myostatin-Smad Signaling." Frontiers in Endocrinology 17 (2026): 1788603. https://doi.org/10.3389/fendo.2026.1788603.

MLA (9th ed.) Citation

Y, Son, et al. "Epigenetic Inhibition of Class I Histone Deacetylases by MS-275 Attenuates Diabetic Skeletal Muscle Atrophy via Akt/ARK5-FoxO and Myostatin-Smad Signaling." Frontiers in Endocrinology, vol. 17, 2026, p. 1788603, https://doi.org/10.3389/fendo.2026.1788603.